David Brassat
AuthID: R-00G-A73
1
TÃTULO: Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting
AUTORES: Philipp Albrecht; Ingrid Kristine Bjorna; David Brassat; Rachel Farrell; Peter Feys; Jeremy Hobart; Raymond Hupperts; Michael Linnebank; Jozef Magdic; Celia Oreja Guevara; Carlo Pozzilli; Antonio Vasco Salgado; Tjalf Ziemssen;
PUBLICAÇÃO: 2018, FONTE: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, VOLUME: 11
AUTORES: Philipp Albrecht; Ingrid Kristine Bjorna; David Brassat; Rachel Farrell; Peter Feys; Jeremy Hobart; Raymond Hupperts; Michael Linnebank; Jozef Magdic; Celia Oreja Guevara; Carlo Pozzilli; Antonio Vasco Salgado; Tjalf Ziemssen;
PUBLICAÇÃO: 2018, FONTE: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, VOLUME: 11
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: CD80(+) and CD86(+) B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis Full Text
AUTORES: Soraya Maria Menezes; Daniele Decanine; David Brassat; Ricardo Khouri; Saul V Schnitman; Ramon Kruschewsky; Giovanni Lopez; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Anne Mieke Vandamme; Bernardo Galvao Castro; Roland Liblau; Johan Van Weyenbergh;
PUBLICAÇÃO: 2014, FONTE: JOURNAL OF NEUROINFLAMMATION, VOLUME: 11, NÚMERO: 1
AUTORES: Soraya Maria Menezes; Daniele Decanine; David Brassat; Ricardo Khouri; Saul V Schnitman; Ramon Kruschewsky; Giovanni Lopez; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Anne Mieke Vandamme; Bernardo Galvao Castro; Roland Liblau; Johan Van Weyenbergh;
PUBLICAÇÃO: 2014, FONTE: JOURNAL OF NEUROINFLAMMATION, VOLUME: 11, NÚMERO: 1
